COVID-19 OUTDOOR RESTAURANT ORDERED TO CLOSE ABRUPTLY IN MORGAN HILL BY ARMED OFFICERS

Ladera Grill in downtown Morgan Hill

Ladera Grill operated outdoor dining only

LADERA GRILL, OUTDOOR RESTAURANT IN MORGAN HILL, WAS ORDERED TO CLOSE ABRUPTLY TONIGHT BY ALCOHOLIC BEVERAGE CONTROL

MORGAN HILL, CALIFORNIA, UNITED STATES, July 4, 2020 /EINPresswire.com/ — BREAKING NEWS PRESS CONFERENCE

LADERA GRILL, OUTDOOR RESTAURANT IN MORGAN HILL, WAS ORDERED TO CLOSE ABRUPTLY TONIGHT BY ALCOHOLIC BEVERAGE CONTROL

WHAT:
Two armed officers from the Alcoholic Beverage Control (ABC), an agency of the State of California, abruptly entered Ladera Grill, a prominent Morgan Hill restaurant, on Friday at 8:20 pm, ordered them to close all operations, and threatened to cite owners, managers, and customers for dining outside. Other restaurants in downtown Morgan Hill and Gilroy were allegedly ordered to close by the ABC without prior notice.

WHEN:
Saturday, July 4, 2020

TIME:
10:00 am

WHERE:
Ladera Grill
17305 Monterey Rd.
Morgan Hill, CA 95037

WHO:
Rich Constantine, Mayor of Morgan Hill
Dan McCranie, Owner, Ladera Grill
Chris Provini, Manager, Ladera Grill

Contact:
Dan McCranie, Ladera Grill
(408) 930-2048 | https://www.laderagrill.com

Terry Downing, PRxDigital
(408) 838-0962 | terry_downing@prxdigital.com

About Ladera Grill and Dan McCranie:

Dan McCranie is an established member of Silicon Valley. He is currently an advisor to Renascia, an independent financial advisory firm focusing on the global technology industry. Dan has over 40 years of strategic semiconductor experience and a vast network of connections in the Bay Area.

Consistently considered one of the top restaurants in Silicon Valley, Ladera Grill strives to provide the best restaurant experience you have ever had. Ladera Grill resides in the historic Skeels Building on Monterey and Third Street in downtown Morgan Hill. The building was originally a residential hotel and restaurant operated by Harry and Cynthia Skeels from 1925 to 1948.

In 1926, the Skeels welcomed Swedish Crown Prince Gustav Adolph and his wife Crown Princess Louise, who were in town to dedicate the new 106-acre Sveadal resort in nearby Uvas Canyon. After a formal procession down Monterey Road, the royal couple checked in to the Skeels Hotel and warmly greeted the crowd of more than 500 local citizens from the balcony of their second-story room.

In 1992, the historic hotel was completely rebuilt as a mixed-use building with apartments upstairs and a modern commercial/restaurant space on the ground floor. The Morgan Hill Historical Society retained the building’s original flagpole, which has been reinstalled on the roof of the new building.

Teresa M Downing
PRxDigital Silicon Valley
+1 4088380962
email us here


Source: EIN Presswire

Human Brain Project announces new phase

Measurement of the brain's nerve fiber architecture for 3D reconstruction on EBRAINS

Measurement of the brain’s nerve fiber architecture for 3D reconstruction

EBRAINS Infrastructure

Overview of the digital EBRAINS research infrastructure with its offers for science and industry.

EBRAINS website

All services are made available via the web platform www.ebrains.eu

• The HBP presents its pioneering new Infrastructure EBRAINS to jumpstart a new era in neuroscience

BRUSSELS, BELGIUM, July 4, 2020 /EINPresswire.com/ —

• The HBP is targeting brain networks, their role in consciousness, and artificial neural nets

• European Commission funds the project with 150 million Euros from now until 2023

The Human Brain Project (HBP) announces the start of its final phase as an EU-funded FET Flagship. The European Commission has signed a grant agreement to fund the HBP with 150 million Euros from now until 2023. Over the next three years, the project will narrow its focus to advance three core scientific areas – brain networks, their role in consciousness, and artificial neural nets – while expanding its innovative EBRAINS infrastructure. EBRAINS offers the most comprehensive atlas and database on the human brain, directly coupled with powerful computing and simulation tools, to research communities around neuroscience, medicine and technology. Currently transitioning into a sustainable infrastructure, EBRAINS will remain available to the scientific community, as a lasting contribution of the HBP to global scientific progress.

Supercomputers, Big Data Analytics, Simulation, Robots and AI have all become new additions to the “toolbox” of modern neuroscience – a development strongly pushed forward by the HBP and its EBRAINS infrastructure.

Started in 2013 as a FET Flagship project, the HBP is the largest brain science project in Europe. Now entering the final phase of its ten-year lifespan, the project is proud to present its scientific workplan and transformative technological offerings for brain research and brain-inspired research and development.

HBP’s scientific activities in the new phase focus on three topics: networks that are studied across different spatial and temporal scales, their significance for consciousness and disorders of consciousness, and the development of artificial neural networks and neurorobotics.

These topics will be developed hand in hand with the EBRAINS research infrastructure. Likewise, a growing community of external users and partnering projects, researchers working on a range of neuroscientific questions increasingly benefit from the diverse methods that are seamlessly integrated in EBRAINS.

“We will make the infrastructure more efficient, attractive and user-friendly”, says HBP Scientific Research Director Prof. Katrin Amunts. Researchers and engineers are working closely together on this, ‘co-designing’ technical solutions that fit the science needs perfectly. This creates a win-win situation for both communities, Amunts says.

Following this approach, research into the functioning of the human brain and its diseases flowed into constructing novel digital tools for a data-driven, interdisciplinary and collaborative approach. "We needed a broad spectrum of neuroscientific fields to do justice to the complexity of the brain, and permanent coordination with the engineers and developers to be able to handle the enormous amounts of data involved, bridging the scales of brain organization from the molecular level to the whole organ.” Much has been achieved in this way, reflected in over 1200 scientific publications to date and a rapidly growing number of users and partners.

EBRAINS today already provides researchers with a wide spectrum of unique services, resources and technologies, for example, a multi-level human brain atlas, which is navigable in 3D, linked to a growing neuroscientific data base, as well as access to a federated system of most powerful European supercomputers, and brain-inspired "neuromorphic" computers pushing simulation and deep learning analytics to new horizons.

An increasing number of applications are built one these new technologies. A method for personalized modelling of patient brains is currently undergoing clinical trials, the first of its kind. The EBRAINS "Medical Informatics Platform" has been installed in 30 European clinics, enabling to run analysis of patient data, without the highly sensitive information having to leave the hospital. It is expected that this technology will have an impact for future studies of rare diseases.

To help the HBP achieve its goals on both the scientific and infrastructure side, the consortium will be further opened during the new phase. New talent will be brought in through a series of Calls for Expression of Interest.

On the institutional side, decisive steps are being taken to ensure the infrastructure reaches its operational maturity after the end of the HBP. In 2019, the EBRAINS AISBL, an international non-profit association under Belgian law, was founded in Brussels with the objective of promoting and supporting brain research. In the coming months, the EBRAINS AISBL will take over the role of the coordinator of the HBP from the Swiss Ecole polytechnique fédérale de Lausanne (EPFL).

An experienced expert on EU research issues from within the European Commission was recruited as founding CEO of EBRAINS and new Director General of the Human Brain Project: Paweł Świeboda joined in May 2020 from his post as Deputy Director and Head of Research at the European Political Strategy Centre, the advisory hub to the Commission President. "EBRAINS is a state-of-the-art digital infrastructure that will be instrumental to secure Europe's place globally in the dynamically growing field of multidisciplinary brain research, with powerful implications for AI, neurorobotics and medicine," Świeboda said.
For the European Research landscape, the HBP has helped to establish a focal point connecting the distributed expertise and resources across the EU: From Germany, for example, world-leading groups come from human brain atlasing, neuromorphic computers, simulation and high-performance computing. France contributes to the project its special expertise in personalized brain models of patients and neuroimaging, Belgium expertise in clinical neuroscience, Norway and Greece in data management, Switzerland in nerve cell simulation, and the Netherlands in linking neurotechnology and cognitive science. "All these groups are working together through the HBP and EBRAINS, creating outcomes together that would have been unthinkable on their own," says Świeboda.

A key objective for the next three years will be to further integrate EBRAINS into the European and global research landscape and to implement new projects with external scientific users. Partnerships with the European Brain Council (EBC) and the project European Research Area for Neurosciences (EBRA), which foster cooperation and convergence between the various activities in Europe, will contribute to this goal. "In this concept, EBRAINS provides the technical platform to facilitate cross-national cooperation and enable faster progress for the benefit of society," says Katrin Amunts.

Peter Zekert
Human Brain Project
+49 2461 6196860
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Vigna Law Group: Fluoroquinolone Use Still Unacceptable Despite Black Box Warnings

Dr. Greg Vigna

Dr. Greg Vigna

Life changing injuries caused by the inappropriate use of the commonly prescribed antibiotic from the fluoroquinolone drug class continues across the USA.

If you have suffered from myasthenia gravis, Guillain-Barre Syndrome, permanent neuropathy, torticollis, or aortic aneurysm following use of Cipro or Levaquin, we are investigating these cases.”

— Dr. Greg Vigna

SANTA BARBARA, CA, UNITED STATES OF AMERICA, July 3, 2020 /EINPresswire.com/ — Life changing injuries caused by the inappropriate use of the commonly prescribed antibiotic from the fluoroquinolone drug class continues across the United States despite a series of Black Box Warnings. The most recent FDA Warning was in March of 2018 and this was a strong recommendation for physicians to avoid the drug class for uncomplicated infections including acute exacerbation of chronic bronchitis, uncomplicated urinary tract infections, and acute bacterial sinusitis.

Greg Vigna, MD, JD, practicing physician, national neurological injury attorney, and Certified Life Care Planner states, “I have practiced medicine since Cipro was brought to the market-place and then Levaquin. These are very effective antibiotics historically used in the treatment of urinary tract infections, community acquired pneumonia, bronchitis, diverticulitis, and sinusitis and were widely used because they can be taken by mouth so they could be used in outpatients since IV administration is not needed.”

Not all black box warnings are equal. In 2008 the FDA published the first black box warning as it related to the fluoroquinolone drug class and it was directed to risks for tendinitis and tendon rupture. In 2013 there was one that related to the potential for irreversible nerve damage. In 2016, there was a warning for the potential for permanent side effects to the central nervous system, peripheral nerves, muscles, and tendons.

Dr. Vigna states, “Which each Black Box Warning a doctor has a legal obligation to warn their patients of the potential complications with use of the drug and possible alternative therapies. If that warning does not occur and there is no consent by the patient and there is harm as described by the Black Box Warning there is a basis for a lawsuit. If Cipro or Levaquin is prescribed for a medical problem that the FDA states that physicians should not prescribe drug and there is injury, there is a basis for a lawsuit.”

Dr. Vigna concludes, “If you have suffered from myasthenia gravis, Guillain-Barre Syndrome, permanent neuropathy, torticollis, or aortic aneurysm following use of Cipro or Levaquin, we are investigating these cases. These injuries require life-time care and these patients require compensation. We focus on severe neurological injuries and injuries that require long-term care. There may be a basis for a malpractice action against a physician or hospital if a quinolone is used and injury occurs.”

Click here for a FREE BOOK on Pelvic Mesh Pain.

Greg Vigna, MD, JD
Vigna Law Group
1155 Coast Village Rd., Suite 3, Santa Barbara, CA
https://vignalawgroup.com

Greg Vigna
Greg Vigna, M.D., J.D., PLC
+1 800-761-9206

References: https://dason.medicine.duke.edu/sites/dason.medicine.duke.edu/files/impact_of_fda_black_box_warning_on_fluoroquinolone_and_alternative_antibiotic_use_in_southeastern_us_hospitals.pdf

https://paltc.org/publications/black-box-warning-about-fluoroquinolone-use

https://www.goodrx.com/blog/fluoroquinolone-antibiotics-prescriptions-fda-warning-side-effects/#:~:text=The%20FDA%20began%20requiring%20the,for%20tendinitis%20and%20tendon%20rupture.

Greg Vigna
Greg Vigna, M.D., J.D.
+1 800-761-9206
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

A Message to Dr. Ridgeway: “Synthetic slings are not the standard of care”

There is a large percentage of urologists, gynecologists, and urogynecologists who don’t place TOT slings because of catastrophic, life-altering pain syndromes.

…a substantial percentage of urologists, gynecologists, & urogynecologists… don’t place TOT slings because of catastrophic, life-altering pain syndromes caused by obturator and pudendal neuralgia.”

— Dr. Greg Vigna

SANTA BARBARA, CA, UNITED STATES OF AMERICA, July 3, 2020 /EINPresswire.com/ — Cleveland Clinic’s Chair of its Obstetrics and Gynecology & Women’s Health Institute, Dr. Beri Ridgeway, in a 2019 presentation stated mid-urethral synthetic polypropylene slings are the “definite standard of care” after being cautioned by an anonymous note to “think very carefully about what I’d be talking about during my presentation on synthetics” and that note related to the “deep controversy over the use of transvaginal synthetic mesh products… linked to a long list of serious adverse effects.”

Dr. Ridgeway in her presentation went through the normal spiel of how transobturator slings pose “less risk of bladder and vascular injury” and single-incision slings are “up-and-coming options” and alternative treatments for SUI (stress urinary incontinence) have limitations.” Unfortunately, Dr. Ridgeway is biased as she is a consultant for Coloplast and is an independent contractor and consultant and key opinion leader subject for Ethicon which are two of the three largest manufacturers of polypropylene slings in the world.

Greg Vigna, MD, JD, national pharmaceutical injury attorney, practicing physician, and Certified Life Care Planner states, “There is a substantial percentage of urologists, gynecologists, and urogynecologists who don’t place transobturator (TOT) slings because of catastrophic, life-altering pain syndromes caused by obturator neuralgia and pudendal neuralgia. In fact, some in Dr. Ridgway’s own department don’t place TOT slings.”

Dr. Vigna adds, “Courts in California and Australia labelled the leading defense experts against Ethicon as ‘biased and unreliable’ and now Dr. Ridgeway is following the same path. My legal teams have combination physician malpractice product cases progressing in Oregon, New York, Texas, and will be filing a TVT-O claim in Boston. Academic physicians from reputable teaching institutions may be named defendants in appropriate circumstances for the foreseeable and unavoidable neurological injuries caused by TOTs and mini-slings that insert on the obturator internus.”

Dr. Vigna is a California and Washington DC lawyer who focuses on catastrophic neurological injuries caused by transvaginal mesh devices including pudendal neuralgia, obturator neuralgia, ilioinguinal neuralgia, and Complex Regional Pain Syndrome. He has filed cases around the country with Martin Baughman, a Dallas Texas firm. Ben Martin and Laura Baughman are national pharmaceutical injury trial attorneys in Dallas, Texas.
For articles, video resources, and information visit the Pudendal Neuralgia Educational Portal or https://tvm.lifecare123.com/.

Click here for information regarding sling related complications and click here for a FREE BOOK on Vaginal Mesh Pain.

Vigna Law Group
1155 Coast Village Rd., Suite 3, Santa Barbara, CA
1-800-761-9206

Reference: https://www.mdedge.com/obgyn/article/194003/surgery/despite-concerns-synthetic-slings-are-still-standard-care-sui

Greg Vigna
Greg Vigna, M.D., J.D., PLC
+1 800-761-9206
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

CEIBA HEALTHCARE PARTICIPATED AT THE WORLD’s LARGEST TELEHEALTH EVENT

COVID 19 solution- CEIBA TELEHEALTH MOBILE CART

CEIBA HEALTHCARE SHARES FEEDBACK FROM ATA CONFERENCCE

CEIBA Healthcare is an end to end full spectrum, integrated tele-healthcare company. We are very honored and proud to be part of this great event as the next generation virtual care platform.”

— Mr. Afsin Alp, the Chairman of CEIBA HEALTH CARE

NEW YORK, NY, UNITED STATES, July 3, 2020 /EINPresswire.com/ — CEIBA Healthcare, the first and only company to offer a Fully Integrated TeleHealth Solution with a decentralized mHealth platform, participated at the ATA 2020 (American Telemedicine Association) Virtual Conference from June 22-26th, 2020.

ATA Annual Conference and Expo (ATA2020) is the world’s largest telehealth innovation event, where providers, technology developers, business professionals and leaders from across the healthcare sector come together virtually to have an in-depth, thoughtful, critical discussion about the future of health.

CEIBA Healthcare participated in this prestigious world known Conference, and Expo with its 4 main product lines: eConnect, eClinics, Dr. ICU and ZeqAI.

Mr. Afsin Alp, the Chairman of CEIBA Healthcare stated: “ We are very honored and proud to be part of this great event as the next generation virtual care platform. At CEIBA, we solve the interoperability issue via its eConnect IoMT platform. eConnect is an open architecture platform where any medical device or third-party software can easily integrate using our open APIs. Integration with eConnect is as easy as “plug and play” and is absolutely brand agnostic. Also, we have the largest ICU unit in the world. We were thrilled to showcase our mHealth platform “Dr ICU” . We had a very large interest at the Expo to view how Dr. ICU transforms the Tele Health in critical care processes into a single mobile platform. Dr. ICU helps clinicians access historic progress notes, lab results, treatments and monitor patient’s vitals in real time. Clinicians can take action from the alarms, can write daily progress notes and can share consultation. It enables the providers to form virtual teams to leverage their work force and create efficiencies. Dr. ICU is designed to democratize and decentralize the way Tele Health service is being delivered for critical care settings. I invite all the ATA attendees to come and see our platform also at our newly developed website “

eConnect’s proprietary technology enables the receipt of continuous live stream of data from any medical device, EHR and presents the patient monitor and ventilator data in wave forms.

eClinics is a specialized platform where all critical patients in different care settings (such as Hospitals, LTACs, SNFs etc.) can be monitored from a single Tele-Health platform. With the continual data-stream of patient information from multiple interfaces and the ability to interact with the bedside via purpose-built 2-way without any hardware dependency conferencing, a physician working from a care center or any remote location can seamlessly support care for a patient in another center. Clinicians may use proprietary acuity scoring, instant waveforms and monitor smart alarms to help identify patients who are at high risk or who are demonstrating early deterioration.

In its fight with the pandemic COVID 19, CEIBA offers the CEIBA TELEHEALTH MOBILE CART and the most comprehensive TELE ICU SERVICE . See at http://www.ceiba-healthcare.com/covid-19.html

Mr. Afsar Alp, the CEO of CEIBA Health Care added: “During the ATA Conference, we conducted very successful one to one meetings with hospitals, doctors and potential partners. We have been looking for partnerships to expand our technology and ATA gave us the best platform to succeed in or goal. We also discussed and talked about how CEIBA responded to the COVID-19 pandemic and how we worked with customers around the world in developing telehealth solutions to support front-line care professionals. Our e-connect rapidly expands and doubles the ICU beds in hospitals within days. We support the international response to Covid-19 by enabling increase in surge capacity; increasing efficiency & staffing Ratio and minimizing risk exposure.”

About CEIBA Healthcare: CEIBA Healthcare is the first and only Healthcare Technology company to offer a HW Dependency Free, Multi-Specialty Virtual Care and the mHealth Platform as the Single Solution for the Continuum of Care. CEIBA Healthcare is an end to end full spectrum, integrated tele healthcare company.Ceiba Healthcare has 3 main solutions in the telemedicine arena:

1) Real Time Remote Patient Monitoring Solution powered by Medical Device Integration,
2) Telehealth Platform powered by AI for Critical Care
3) mHealth Platform for Critical Care
Please check our catalog for more information about each function.

About: ATA 2020 Annual Virtual Conference and Expo
The 2020 ATA Annual conference took place virtually between June 22 – 26, 2020. Participants had access to keynote discussions and panel sessions ranging in topics from interoperability and cybersecurity, to remote patient monitoring and disparity within telehealth offerings.

Melike Ayan
mel strategies
+1 212-980-8090
email us here


Source: EIN Presswire

Mountz Introduces the New FGC Cam-Over Torque Wrench

Engineered with a cam-over technology, the FGC wrench prevents over-torque.

Safeguarding against fastening failures, the precision tool delivers accuracy and repeatability delivered for tightening applications

SAN JOSE, CA, USA, July 3, 2020 /EINPresswire.com/ — Mountz, The Torque Tool Specialist ®, introduces the next generation in cam-over wrench technology. Engineered and assembled in Silicon Valley, the FGC line of precision preset cam-over wrenches are the most advanced torque wrenches for high-level process and quality control. The wrench’s repeatability, traceability, and precision will prevent tightening failures.

Surpassing the ISO 6789 standard of 5,000 cycles before to re-calibration, the FGC wrenches stay in calibration 2X longer than the stringent industry standard and deliver an unprecedented wrench calibration life with 10,000 cycles. Mountz FGC torque wrenches are constructed from high-quality materials, designed for superior reliability and safety and backed by an industry-leading warranty.

Engineered with a cam-over technology, the poka-yoke wrench prevents over-torque. The wrench uses an internal cam-over mechanism to physically prevent the operator from over-torquing fasteners by slipping, or disengaging once torque is reached. Even if an operator tries to use the tool on the same fastener after it has slipped, the tool will simply slip again, refusing to deliver more torque than specified. The Mountz cam-over technology increases the consistency of torque delivered and joint reliability.

Safeguarding against fastening failures, this error-proofing wrench removes the operator's influence out of the torque equation and delivers an accurate and repeatable fastening result than a standard click type wrench. A manufacturer can provide the FGC cam-over wrench to any operator and have the confidence that he/she will deliver the correct torque, time after time.

The FGC is a preset cam-over torque wrench that improves productivity by guaranteeing that the correct torque value is consistently applied to each fastener. Preset cam-over wrenches are ideal for fastening applications where operators repeatedly assemble parts at the same torque setting. The preset wrench does not feature an external adjustment scale. These tools have an internal torque adjustment mechanism that must be preset using a torque tester. The locking mechanism prevents incidental adjustments or the operator tampering with the torque setting. Once the tool is set the wrench's end cap is sealed with a calibration sticker and ready to be used for tightening fasteners.

The FGC features a cushion, non-slip ergonomic grip that improves the operator's efficiency by reducing discomfort, fatigue, and risk of injury. Manufactured with a corrosion-resistant stainless steel head, Mountz offers various models covering a torque range capacity from 8.9 inch-pounds up to 92.2 foot-pounds.

As "the torque tool specialists", Mountz has a fifty-five-year history of bold thinking and a 100% focus on torque that delivers confidence at every turn. From the development of the first electronic torque analyzer that launched a new product category, Mountz has always pursued new torque innovations, like cam-over technology, to help our customers optimize precision, accuracy, and quality across their manufacturing processes. Quality is at the heart of everything we do.

Chris Morris
Mountz Inc.
+1 408-292-2214
email us here


Source: EIN Presswire

TheAppLabb donates a gift of $20,000 to Holland Bloorview Kids Rehabilitation Hospital Foundation

TheAppLabb donates a gift of $20,000 to Holland Bloorview Kids Rehabilitation Hospital Foundation along with Srinarayanathas Foundation

TORONTO, ONTARIO, CANADA, July 3, 2020 /EINPresswire.com/ — During this exceptional unprecedented time, it's a matter of privilege to be in a position to spread happiness in the local community. The act of giving to the ones who need it the most can be an immense source of inspiration. Last week, TheAppLabb's CEO, Kundan Joshi along with Muraly Srinarayanathas, Deputy Chair, Srinarayanathas Foundation presented a gift of $20,000 in a socially distant way to the Sandra Hawken, President and CEO, Holland Bloorview Kids Rehabilitation Hospital Foundation.

Holland Bloorview Kids Rehabilitation Hospital Foundation supports a lot of amazing programs aimed at creating a world of possibilities for kids and youth of diverse groups with disabilities through specialized programs, clinical care, rehabilitation and complex care. The donation was made to provide support towards research, programs and services for these kids.

TheAppLabb and Srinarayanathas Foundation joined hands for the inaugural Paddle for Good Charity Tournament held earlier in March 2020, an initiative to donate up to $20,000 for a charity or non-profit of choice. TheAppLabb won the table-tennis tournament and chose the Holland Bloorview Kids Rehabilitation Hospital Foundation as their charity.

Kundan Joshi, TheAppLabb's CEO said, "It feels incredibly privileged especially in today's times of greater need, to contribute towards a great local cause. TheAppLabb's purpose is to enable technology and innovation to deliver positive social impact and it's our honor to contribute to an organization that creates innovative programs to support and empower kids with disabilities. It feels great to have made a meaningful difference in the lives of these wonderful kids."

About Holland Bloorview Kids Rehabilitation Hospital

Holland Bloorview Kids Rehabilitation Hospital creates a world of possibility by supporting children and youth living with disability, medical complexity, illness and injury. Holland Bloorview is a top 40 Canadian research hospital that is fully affiliated with the University of Toronto and serves over 7,500 families annually. Website: www.hollandbloorview.ca/

About TheAppLabb

TheAppLabb is a Toronto based mobile innovation company focused on strategy, design and development of exceptional apps that create impact and drive business outcomes. TheAppLabb's SaaS based platforms provide built-in intelligence and scalability to help retailers, consumer goods companies, healthcare companies etc. transform their digital journey. Over 13 years, TheAppLabb has built more than 500 apps with their passion and expertise in technology helping businesses master their domain and mark themselves as leaders of the future. Website: www.theapplabb.com/

SOURCE TheAppLabb
Press Release Link: https://www.newswire.ca/news-releases/theapplabb-donates-a-gift-of-20-000-to-holland-bloorview-kids-rehabilitation-hospital-foundation-along-with-srinarayanathas-foundation-886332763.html

For further information: Media Contact: Hardik Dave, 437-688-4840, hardik@theapplabb.com

Hardik Dave
TheAppLabb
+1 437-688-4840
email us here
Visit us on social media:
Twitter
LinkedIn


Source: EIN Presswire

Pain Monitoring Device Market 2020 Global Trends, Share, Growth, Analysis, Opportunities and Forecast To 2026

A new market study, titled “Pain Monitoring Device Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, July 3, 2020 /EINPresswire.com/ — Introduction
Pain Monitoring Device Market
This report presents a comprehensive overview, market shares, and growth opportunities of Pain Monitoring Device market by type, application, key manufacturers and key regions and countries.
This study considers the Pain Monitoring Device value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Radiofrequency Ablation Device
Neurostimulators
Others

@Get a Free Sample Report on Pain Monitoring Device Industry Market 2020 https://www.wiseguyreports.com/sample-request/5206086-global-pain-monitoring-device-market-growth-2020-2025
If you have any special requirements, please let us know and we will offer you the report as you want.

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Ambulatory Surgical Centers

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medasense Biometrics
Delta Medical International
Medtronic
Stryker
AngioDynamics
Abbott
Mdoloris Medical Systems

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Pain Monitoring Device consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Pain Monitoring Device market by identifying its various subsegments.
Focuses on the key global Pain Monitoring Device manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pain Monitoring Device with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pain Monitoring Device submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

@Ask Any Query on Pain Monitoring Device Market 2020 Size, Share, demand https://www.wiseguyreports.com/enquiry/5206086-global-pain-monitoring-device-market-growth-2020-2025

Major Key Points of Global Pain Monitoring Device Market
1 Scope of the Report
2 Executive Summary
3 Global Pain Monitoring Device by Company
4 Pain Monitoring Device by Regions
9 Market Drivers, Challenges and Trends
10 Marketing, Distributors and Customer
11 Global Pain Monitoring Device Market Forecast
12 Key Players Analysis
13 Research Findings and Conclusion

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire

N95 Children Masks Market 2020 Global Trends, Share, Growth, Analysis, Opportunities and Forecast To 2026

PUNE, MAHARASTRA, INDIA, July 3, 2020 /EINPresswire.com/ — Introduction
N95 Children Masks Market
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

This report presents a comprehensive overview, market shares, and growth opportunities of N95 Children Masks market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the N95 Children Masks, covering the supply chain analysis, impact assessment to the N95 Children Masks market size growth rate in several scenarios, and the measures to be undertaken by N95 Children Masks companies in response to the COVID-19 epidemic.

@Get a Free Sample Report on N95 Children Masks Industry Market 2020 https://www.wiseguyreports.com/sample-request/5318247-global-n95-children-masks-market-growth-2020-2025
If you have any special requirements, please let us know and we will offer you the report as you want.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Flat-fold Type
Cup Type

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
3 to 6 Years Old
7 Years Onwards
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
• 3M
• Gerson
• Honeywell
• Cardinal Health
• Ansell
• Kimberly-clark
• Chirpa
• DACH Schutzbekleidung
• CM Mask
• Aniwon
• Shanghai YuanQin
• AIR+ Family
• Winner Medical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global N95 Children Masks consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of N95 Children Masks market by identifying its various subsegments.
Focuses on the key global N95 Children Masks manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the N95 Children Masks with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of N95 Children Masks submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

@Ask Any Query on N95 Children Masks Market 2020 Size, Share, demand https://www.wiseguyreports.com/enquiry/5318247-global-n95-children-masks-market-growth-2020-2025

Major Key Points of Global N95 Children Masks Market
1 Scope of the Report
2 Executive Summary
3 Global N95 Children Masks by Company
4 N95 Children Masks by Regions
9 Market Drivers, Challenges and Trends
10 Marketing, Distributors and Customer
11 Global N95 Children Masks Market Forecast
12 Key Players Analysis
13 Research Findings and ConclusionList of Tables

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire

Face Mask Machines Market 2020 Global Trends, Share, Growth, Analysis, Opportunities and Forecast To 2026

Face Mask Machines

A new market study, titled “Face Mask Machines Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, July 3, 2020 /EINPresswire.com/ — Introduction
Global Face Mask Machines Market
This report presents a comprehensive overview, market shares, and growth opportunities of Face Mask Machines market by type, application, key manufacturers and key regions and countries.

This study considers the Face Mask Machines value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Vertical Face Mask Machine
Flat Mask Machine

@Get a Free Sample Report on Face Mask Machines Industry Market 2020 https://www.wiseguyreports.com/sample-request/5156507-global-face-mask-machines-market-growth-2020-2025
If you have any special requirements, please let us know and we will offer you the report as you want.

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Health Care
Food Processing
Electronics Industry
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
ZHIYUN
Dongguan Licheng machinery equipment
Dongguan Chuangyu Ultrasonic Machinery
Dongguan Huitong Automation Equipment
Broadfair Automation Equipment Co., Ltd.
Dongguan BangYin Machinery Co., Ltd.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Face Mask Machines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Face Mask Machines market by identifying its various subsegments.
Focuses on the key global Face Mask Machines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Face Mask Machines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Face Mask Machines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

@Ask Any Query on Face Mask Machines Market 2020 Size, Share, demand https://www.wiseguyreports.com/enquiry/5156507-global-face-mask-machines-market-growth-2020-2025

Major Key Points of Global Face Mask Machines Market
1 Scope of the Report
2 Executive Summary
3 Global Face Mask Machines by Company
4 Face Mask Machines by Regions
9 Market Drivers, Challenges and Trends
10 Marketing, Distributors and Customer
11 Global Face Mask Machines Market Forecast
12 Key Players Analysis
13 Research Findings and Conclusion

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire